Medex Medical Supplies INC

Medex Medical Supplies INC was paid $9.93M by Medicaid between Jun 2022 and Dec 2024, across 7 billing codes. Its largest line is 87637, Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV — 41% of everything it billed.

33Billing provider infoMEDEX MEDICAL SUPPLIES INC
HOFFMAN ESTATES, IL 60169

33aNPI1427703727assigned 02/15/2022

33bProvider typeClinical Medical Laboratory

28Total paid$9.93M

24GClaims175,382

24DCodes billed7

24AFirst – last monthJun 2022 – Dec 2024

Compared with peers

Next to other Clinical Medical Laboratory providers in Illinois

Rank by total paid#17 of 235

Median peer was paid$123K

This provider vs. median81×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2022	24,608	$1.04M
2023	129,064	$6.24M
2024incomplete	21,710	$2.65M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	41%	33,070	18,378	$4.03M
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	32%	43,165	13,257	$3.20M
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	11%	47,823	13,425	$1.11M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	9.3%	37,614	13,282	$928K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	6.6%	13,649	5,947	$659K
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	<1%	26	26	$1K
K1034	Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count	0%	35	31	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSIDDIQUI, TARIQ (PRESIDENT)